前端編輯

管理員身份可於登入後,進行網站的前端管理。

Electronegative low-density lipoprotein (LDL) found in human plasma is highly atherogenic, and its level is elevated in individuals with increased cardiovascular risk. In this review, we summarize the available data regarding the elevation of the levels of electronegative LDL in the plasma of patients with various diseases. In addition, we discuss the harmful effects and underlyingmechanisms of electronegative LDL in various cell types. We also highlight the known biochemical properties of electronegative LDL that may contribute to its atherogenic functions, including its lipid and protein composition, enzymatic activities, and structural features. Given the increasing recognition of electronegative LDL as a potential biomarker and therapeutic target for the prevention of cardiovascular disease, key future goals include the development of a standard method for the detection of electronegative LDL that can be used in a large-scale population survey and the identification and testing of strategies for eliminating electronegative LDL from the blood. Curr Atheroscler Rep (2014) 16:428
 
L5 chemsitry-Curr Athero Rep 2014
附件下載
FileFile sizeLast modified
Download this file (L5 chemsitry-Curr Athero Rep 2014.pdf)L5 Chemistry Review2217 kB2014-07-31
Go to top